Daniel S. Brandwein, D.P.M.’90, FACFAS, Florida board-certified foot and ankle surgeon, joined the board of directors of CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corp., a provider of innovative phytonutrient-based food and nutritional products. In addition to his expertise in pain management and therapeutic treatments, Dr. Brandwein has participated in clinical trials and has authored several scientific papers. He did clinical trials with Yale University and Dan Kiddy, D.P.M.’90, for peripheral neuropathy treatment.
“During an original clinical study in 2015, which was supported by CBD Unlimited, I observed and administered a CBD trial for one month through my practice. After the month-long trial, my patients were reporting relief from pain and tension,” Dr. Brandwein said. “From there, I knew that I needed to be part of something special and cutting-edge in order to provide the very best care to my patients and to patients around the world.”
